Oxoflaccidin is primarily studied for its potential biological activity, particularly in the field of cancer research. It has shown cytotoxic effects against certain tumor cell lines, making it a compound of interest in the development of anticancer agents. Its mechanism appears to involve the induction of apoptosis and interference with cell cycle progression in malignant cells. Due to its natural origin and structural complexity, oxoflaccidin also serves as a lead compound for the synthesis of derivatives aimed at improving potency and selectivity. Research is ongoing to evaluate its efficacy and safety in preclinical models.